Skip to main content
. 2018 May 3;35(5):671–685. doi: 10.1007/s12325-018-0700-6

Table 1.

Patient cohorts, by payer

Commercial Medicare Medicaid
Enrolled patients 11,053,733 1,229,651 2,791,550
≥18 years of age 10,586,378 1,229,651 2,415,776
Received oral atypical antipsychotic 919,872 136,038 496,092
Enrolled continuously 6 months prior and 12 months after first oral atypical and ≥ 18 in year indexed 366,234 62,946 210,367
Exclude if antipsychotic through mail order 304,118 42,097 207,149
Exclude if index fill for clozapine 303,157 41,945 204,130
Has claims during atypical enrollment window 303,157 41,945 204,130
≥1 inpatient or ≥ 2 outpatient claims with a diagnosis code for SCZ, BPD, or MDD during 6 months prior to index date or 12 months after 241,648 26,502 168,441

SCZ schizophrenia, BPD bipolar disorder, MDD: major depressive disorder